Anti-neoplastic effects of aprotinin on human breast cancer cell lines: In vitro study

Aprotinin is a nonspecific serine protease inhibitor, which can inhibit plasminogen-plasmin system and matrix metalloproteinases. Aprotinin has been investigated as an antitumor agent. However, its antineoplastic effects on breast cancer (BC) have not been investigated yet. The objective of this stu...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2019-02, Vol.28 (2), p.151-157
Hauptverfasser:	Soleyman-Jahi, Saeed, Sadeghi, Fatemeh, Afshari, Ziba, Barati, Tahereh, Ghasemi, Sevil, Muhammadnejad, Samad, Amanpour, Saeid, Zendehdel, Kazem
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - pharmacology Aprotinin - pharmacology Breast Neoplasms - drug therapy Breast Neoplasms - metabolism Cell Line Cell Line, Tumor Cell Proliferation Humans Neoplasm Invasiveness Serine Proteinase Inhibitors - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!